United States· US:0037-6860_9a4c3abc-74c9-4a2c-a8e3-fc0100d873d9

Dipentum

A medicinal product containing olsalazine sodium, registered in United States by Viatris Specialty LLC.

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedDipentumATC—REGISTER NO.US:0037-6860_9a4c3abc…PACKS LISTED1CHECKEDSeptember 12, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
olsalazine sodium
Manufacturer
Viatris Specialty LLC
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 12, 2026

Packs & prices · 1

  • ndc11
    0037686010
    100 CAPSULE, GELATIN COATED in 1 BOTTLE, PLASTIC (0037-6860-10)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Olsalazine sodium in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All olsalazine sodium products

Authorised across Europe · EMA

The same active substance is authorised in 10 EEA countries. Names it is sold under:

  • Germany · Dipentum
  • Denmark · Dipentum
  • Finland · Dipentum
  • France · Dipentum
  • United Kingdom (Northern Ireland) · Olsalazine Sodium Atnahs Pharma Uk
  • Ireland · Dipentum
  • Iceland · Dipentum
  • Netherlands · Dipentum
  • Norway · Dipentum
  • Sweden · Dipentum

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/0d652c2c-d162-45e6-9417-51b34646053b
GET /v1/drugs/0d652c2c-d162-45e6-9417-51b34646053b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "livertox": {
    "summary": null,
    "livertox_id": null,
    "hepatotoxicity_score": 3
  },
  "productid": "0037-6860_9a4c3abc-74c9-4a2c-a8e3-fc0100d873d9",
  "productndc": "0037-6860",
  "dosage_form": "CAPSULE, GELATIN COATED",
  "dea_schedule": null,
  "product_type": "HUMAN PRESCRIPTION DRUG",
  "substance_name": "OLSALAZINE SODIUM",
  "proprietary_name": "Dipentum",
  "active_ingred_unit": "mg/1",
  "application_number": "NDA019715",
  "marketing_category": "NDA",
  "nonproprietary_name": "olsalazine sodium",
  "start_marketing_date": "20150515",
  "active_numerator_strength": "250"
}

See everything about olsalazine sodium.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.